Onderneming Alzheon, Inc.
Aandelen
ALZH
US00168L1017
Biotechnologie & Medisch Onderzoek
Vakgebied
Aantal werknemers: 6
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Martin Tolar
FOU | Founder | 59 | 01-06-13 |
Kenneth A. Mace
DFI | Director of Finance/CFO | 52 | 01-09-15 |
Adem Albayrak
COO | Chief Operating Officer | - | 13-09-21 |
Susan Abushakra
CTO | Chief Tech/Sci/R&D Officer | 63 | 01-07-15 |
John A. Hey
CTO | Chief Tech/Sci/R&D Officer | 64 | - |
John J. Haas
LAW | General Counsel | 48 | - |
Aidan Power
PRN | Corporate Officer/Principal | - | 01-06-15 |
Petr Kocis
PRN | Corporate Officer/Principal | - | 01-01-15 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jordan Heller
BRD | Director/Board Member | 62 | 08-01-20 |
Chairman | 80 | 06-08-18 | |
Martin Tolar
FOU | Founder | 59 | 01-06-13 |
Diane Jorkasky
BRD | Director/Board Member | 72 | 01-12-19 |
Christopher Dunn
BRD | Director/Board Member | 64 | 08-01-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 16 268 967 | 0 | 0 | - |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+17,96% | 44,96 mld. | |
+48,77% | 41,85 mld. | |
+1,17% | 42,65 mld. | |
-4,27% | 29,04 mld. | |
+11,42% | 26,08 mld. | |
-21,39% | 19,03 mld. | |
+4,86% | 12,75 mld. | |
+27,29% | 12,06 mld. | |
-3,50% | 11,75 mld. |